A patented RNA-based cocktail developed astatine nan Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged arsenic a promising progressive supplier against tumors of nan cardinal tense system, specified arsenic glioblastoma. The study, published coming successful nan technological diary Molecular Therapy – Nucleic Acids, demonstrates nan effectiveness of a operation of 11 different non-coding RNAs, known arsenic microRNAs (miRNAs), successful slowing nan maturation of crab cells and enhancing nan activity of chemotherapeutic drugs. Tests were carried retired connected patient-derived cells and connected preclinical models. Further validation steps will beryllium required for aesculapian usage of nan compound.
The protocol was developed by nan Neurobiology of microRNA Laboratory of IIT, coordinated by Principal Investigator Davide De Pietri Tonelli. The study besides progressive researchers from IIT's Nanotechnology for Precision Medicine Laboratory, led by Paolo Decuzzi, nan IIT Analytical Chemistry Laboratory, nan University of Genoa and nan IRCCS Policlinico San Martino. The experimental activity was supported by grants from Fondazione AIRC for Cancer Research, coordinated by De Pietri Tonelli.
Glioblastoma is 1 of nan astir fierce encephalon tumors, and IIT's researchers person identified a caller miRNA-based therapeutic strategy tin of slowing its progression and making it much responsive to anticancer narcotics specified arsenic temozolomide. The aforesaid strategy could perchance beryllium applied to different tumor types, arsenic it targets biologic mechanisms of adhesion and penetration shared crossed different kinds of crab cells.
Internationally, galore objective tests are testing RNA-based therapeutics, which usually trust connected a azygous RNA molecule that tumors tin yet find ways to evade. By utilizing a cocktail of miRNAs, this anticipation is reduced, because each miRNA acts connected aggregate fronts, giving tumor cells acold little opportunities to resume their growth."
Davide De Pietri Tonelli, coordinator of nan IIT MicroRNA Neurobiology Laboratory
The investigation squad focused connected miRNAs, a type of non-coding RNA progressive successful cistron regularisation and successful nan cardinal biologic mechanisms that govern compartment behavior, stimulating aliases inhibiting their growth. In particular, nan researchers studied miRNAs progressive successful nan differentiation of stem cells into neurons-a process known arsenic neurogenesis, which generates and maintains patient cells successful nan cardinal nervous system, and done this activity they identified 11 chopped miRNA molecules.
When a tumor is present, nan molecular mechanisms controlled by these miRNAs go altered. Cancer cells proliferate done 2 main strategies: by lowering nan levels of controls, specified arsenic miRNAs that would inhibit their growth, and by seeking nutrients and power from humor vessels to support their section and description .
The squad demonstrated that introducing that operation of 11 miRNAs into nan tumor slows nan maturation and invasiveness of glioblastoma cells. Tests were performed connected tumor cells extracted from patients and connected preclinical models.
"Through our familial and computational studies, we recovered that these miRNAs activity together to slow-down tumor growth, by blocking circumstantial interactions betwixt crab cells and nan situation astir them," says Silvia Rancati, first writer of nan study, a PhD student successful Tonelli's group astatine nan clip and now a postdoctoral interrogator successful IIT's Polymers and Biomaterials Laboratory successful Genoa.
The miRNA operation was delivered utilizing nanoparticles, for illustration those utilized successful RNA vaccines, though transportation methods could alteration depending connected nan type of anticancer therapy required. The patented formulation has proved effective successful nan laboratory and will now request to acquisition a validation process earlier reaching objective application.
"This investigation highlights nan value of curiosity-driven subject and nan spot of multidisciplinary collaboration; we brought together neurobiology, nanotechnology, analytical chemistry and computational biology – coming astatine IIT, alongside nan objective expertise disposable passim nan Ligurian ecosystem," concludes De Pietri Tonelli.
Source:
Journal reference:
Rancati, S., et al. (2025). Synergic microRNAs suppress quality glioblastoma progression by modulating clinically applicable targets. Molecular Therapy Nucleic Acids. doi: 10.1016/j.omtn.2025.102763. https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(25)00317-8
English (US) ·
Indonesian (ID) ·